Pre-Op Clearances: Every Test Your Program May Require and Why

The clearance stage is where most people stall. You get a list of appointments, some make obvious sense, some look like busywork, and nobody explains which is which. Then a result comes back and your date moves. This article walks through what the national guideline actually asks for, and where your program or payer is adding a layer on top. Your surgeon's list wins over anything you read here.

Where the list comes from

Most United States programs work from the 2019 perioperative guideline written jointly by AACE, the American College of Endocrinology, ASMBS, The Obesity Society, the American Society of Anesthesiologists and the Obesity Medicine Association. It carries 85 numbered recommendations, each with a letter grade. Grade A is very strong. Grade D means expert opinion, because the evidence was thin or inconsistent. The grade tells you how much weight a requirement is carrying.

Two early recommendations set the frame. R7 and R8 are both Grade A. The preprocedure evaluation must cover your obesity-related conditions and their causes, and must include a full medical history, a psychosocial history, a physical exam and labs to gauge surgical risk. Nearly everything else is an item inside that, or something a payer added.

The guideline names that difference. R15 says routine TSH screening before a bariatric procedure is not recommended, and in the same breath notes many insurance plans require it anyway. A TSH belongs in the workup when there is clinical evidence of hypothyroidism, and that part is Grade B. The reasoning is that the upper end of the normal TSH range rises with body weight, so screening everyone produces overdiagnosis and unnecessary lifelong thyroid medication.

The bloodwork

The guideline's preprocedure checklist divides labs into surgical safety and nutrition. Safety covers fasting glucose, a lipid panel, kidney function, a liver profile, urinalysis, clotting time and INR, blood type and a complete blood count. R16 makes a fasting lipid panel a Grade A item for everyone with obesity.

The nutrition side is R32, one of the strongest statements in the document. At Grade A, every patient must have a nutritional evaluation including micronutrient measurements before any bariatric procedure, and malabsorptive procedures require a more extensive one. The named panel is iron studies, vitamin B12, folic acid and 25-hydroxy vitamin D, with vitamins A and E optional. Whole-blood thiamine before a bypass is Grade C.

This is why two programs draw different tubes. The guideline's own discussion says ferritin, the fat-soluble vitamins other than vitamin D, and vitamin C need not be ordered routinely before surgery and can be reserved for people at risk. A wide panel and a narrow one are both inside the guidance. The thiamine point is not academic: the guideline cites reported thiamine deficiency in 16 to 47 percent of people awaiting bariatric surgery, depending on the population studied.

Diabetes and glucose targets

R14 is unusually firm. At Grade A, glycemic control before the procedure must be optimized using a full diabetes care plan: a healthy lower-calorie eating pattern, medical nutrition therapy, activity and medication as needed. The numbers themselves are Grade B, because they are associated with shorter stays and better outcomes rather than proven to cause them. Those targets are an A1C of 6.5 to 7.0 percent and periprocedure glucose of 80 to 180 mg/dL.

If you have advanced complications, several other conditions, or long-standing diabetes where good control has been hard to reach despite real effort, the guideline sets a deliberately looser target of 7 to 8 percent, and that looser target is itself Grade A. Above 8 percent, or with otherwise uncontrolled diabetes, the guideline sets no bar at all. It hands the need and the timing back to clinical judgment. Read that as room to work with your team, not a line you have failed to clear.

Upper endoscopy

The 2019 guideline is restrained. R25 says clinically significant gastrointestinal symptoms should be evaluated before surgery with imaging, an upper GI series or endoscopy, and that preoperative endoscopy may be considered in everyone being evaluated for a sleeve. Both halves are Grade D, expert opinion. The discussion explains why the panel stopped there. A United Kingdom survey found no consensus on routine versus selective scoping, reviews of symptomatic patients found endoscopy altered surgical planning in roughly 7 to 12 percent of cases, and the guideline states that whether abnormal preoperative findings predict postoperative complications is not clear from current evidence.

IFSO published a position statement in 2025 that leans further. Because symptoms do not accurately predict pathology before surgery or reflux afterward, it says upper endoscopy should be strongly considered before metabolic bariatric surgery. That is a shift in emphasis rather than a contradiction, and the IFSO authors note their evidence base would rate low or very low under GRADE. Neither document requires scoping everyone, and both leave a program free to do it.

H. pylori screening

R27 is Grade C and narrower than most people assume: routine screening for H. pylori before a bariatric procedure may be considered in areas of high prevalence. It does not say screen everyone everywhere.

The reason for screening is marginal ulcer after gastric bypass, and the guideline cites work reporting a tenfold higher rate of that complication in patients who tested positive. Newer pooled data complicate that. A 2025 systematic review and meta-analysis covering seven studies and 255,899 patients found no significant association between preoperative H. pylori and marginal ulcer after Roux-en-Y gastric bypass, with a risk ratio of 1.16, a confidence interval from 0.23 to 5.88, and very high heterogeneity. Neither result settles it. Testing everyone and testing selectively are both defensible.

Sleep apnea

R22 is Grade C: clinical screening for obstructive sleep apnea, with a confirmatory sleep study if the screen is positive, should be considered. A formal pulmonary evaluation including arterial blood gas is for people with intrinsic lung disease or disordered sleep patterns, and only when the result would change care.

The guideline is candid about the limits. It cites longer hospital stays and higher complication rates in patients with sleep apnea, then says the data on whether screening and treatment actually reduce that risk are mixed, with several studies showing no reduction. Screening is still close to universal. Most programs start with a questionnaire, and the Society of Anesthesia and Sleep Medicine guideline describes STOP-Bang, where a score of 4 is highly sensitive for severe apnea and raising the threshold to 6 trades sensitivity for specificity. That guideline is equally frank that most of its own recommendations came from expert consensus. If you are prescribed CPAP, using it before surgery is one of the few variables here fully under your control.

Heart, lungs and the smaller items

There is no universal cardiac clearance. R21 ties the need for an electrocardiogram and other noninvasive cardiac testing to your individual risk factors and exam findings, following American College of Cardiology and American Heart Association guidance for noncardiac surgery. That is Grade D. Known heart disease means a formal cardiology consultation. The one Grade A element is evaluation for perioperative beta blockade if you are at risk for heart disease. A program that puts an ECG on every chart is following its own policy, not a mandate.

Two smaller items round out the list. Imaging is not recommended as a routine liver screen, at Grade B, though abdominal ultrasound is indicated for symptomatic biliary disease or abnormal liver enzymes, at Grade C. Preprocedure bone density scanning is not supported outside standard osteoporosis rules, at Grade D.

Smoking

This is the least negotiable item on the list. R23 is Grade A: tobacco must be avoided at all times, and people who smoke should stop as soon as possible, preferably a year before the procedure and at the very least 6 weeks before. Continuing afterward is also Grade A against, because of poor wound healing, anastomotic ulcer and worse health generally. The discussion adds that smokers should be urged to quit at any point before surgery, even inside that 6-week window, and cites a series of 12,062 patients in which smoking history rather than BMI was the only predictor of airway complications. Structured cessation programs beat general advice, at Grade D. Some programs test nicotine levels and will cancel. That is the preoperative variable with the most consistent signal behind it.

The behavioral health evaluation

Almost everyone dreads this one, and almost nobody needs to. R30 is Grade C. A formal psychosocial and behavioral evaluation by a licensed behavioral health professional with training relevant to obesity, eating disorders and bariatric procedures should be required for all patients, assessing environmental, family and behavioral factors along with suicide risk. A second Grade C line says anyone with known or suspected psychiatric illness or substance abuse should have a formal mental health evaluation. A third says high-risk groups should stop drinking after bypass and sleeve, because alcohol behaves differently after both.

The domains it lists are the ones you will be asked about: weight history, eating disorder symptoms, psychosocial and family history, mental health treatment, stressors, support, health behaviors including substance use, and what you expect surgery to do. The ASMBS recommendations on this evaluation, published in 2016 by Sogg, Lauretti and West-Smith, describe its purpose as identifying risk factors and likely postoperative challenges and recommending supports. The usual outcome is a recommendation, not a denial. Those authors also note the requirement has been adopted by most third-party payers and by over 80 percent of United States programs, which is another way of saying part of why you are in that chair is billing. It is a conversation about your life, not a test you fail by being nervous.

Preoperative weight loss, the liver, and the insurance version

The first is the short preoperative diet. R12 says weight loss before the procedure can reduce liver volume and may improve the technical aspects of surgery in people with an enlarged or fatty liver, so it may be recommended. It is Grade B, downgraded by the panel for inconsistent evidence. A 2025 systematic review and meta-analysis of 8 trials and 1,197 patients found very low calorie diets associated with fewer perioperative complications, odds ratio 0.59, while low calorie diets showed no significant effect. Operative time was not significantly reduced and hospital stay was shorter by about 0.17 days. The authors rated certainty as low. The diet is defensible, and it is also not the make-or-break event it feels like on day 9 of it.

The second is an insurance mandate to lose weight or document months of supervised dieting before approval. The guideline's evidence review is direct about that. It cites a retrospective review of 1,432 patients where payer-mandated preoperative weight loss showed no link to better 2-year results, other work finding such mandates delay treatment and adversely affect weight outcomes, and an analysis in which a longer required diet was the strongest predictor of people dropping out of the process altogether. The panel's stated conclusion is that these studies argue against making weight loss a prerequisite, because the likely effect of failing is denial of a procedure you need. If your program's liquid diet starts 2 weeks before your date, that is clinical. If your policy demands 6 months of documented dieting first, that is a payer rule the guideline authors do not endorse.

What to do when a requirement looks wrong

Ask three questions, in this order. What is this test looking for. What would change if it came back abnormal. Is this my program's requirement or my insurance policy's requirement. Most coordinators answer all three in a minute, and the third answer tells you who to talk to next.

Programs accredited through the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program work to a standards manual from the American College of Surgeons covering resources, processes, data collection and quality improvement. Accreditation is worth asking about. What it does not do is make every program's checklist identical, and you should not expect it to.